Clinical Trial Update: Evaluating the Indego Exoskeleton for Persons With Hemiplegia Due to CVA [NA]

View source ↗

Summary

Completed clinical trial evaluating the Indego exoskeleton for people with hemiplegia due to cerebrovascular accident (stroke). Results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemiplegia
• Stroke

Drugs mentioned

• Indego Exoskeleton

Snippet

Sponsor: Parker Hannifin Corporation | Conditions: Cerebrovascular Accident (CVA), Stroke | NA | Status: COMPLETED | Results posted: 2020-04-07